Selectis Health (GBCS) Revenue (2010 - 2025)

Selectis Health (GBCS) has 12 years of Revenue data on file, last reported at $9.7 million in Q4 2025.

• Quarterly Revenue fell 6.98% year-over-year to $9.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $41.4 million (up 4.94% YoY) and the FY2025 annual result came in at $41.4 million, up 4.94% from the prior year.
• Revenue declined to $9.7 million in Q4 2025 per GBCS's latest filing, from $10.8 million in the prior quarter.
• The five-year high for Revenue was $11.5 million in Q2 2022, with the low at $5.8 million in Q1 2021.
• Average Revenue over 5 years is $9.4 million, with a median of $9.6 million recorded in 2023.
• Year-over-year, Revenue soared 90.71% in 2022 and decreased 22.13% in 2023.
• Selectis Health's Revenue stood at $10.2 million in 2021, then increased by 5.95% to $10.8 million in 2022, then dropped by 14.78% to $9.2 million in 2023, then climbed by 12.99% to $10.4 million in 2024, then decreased by 6.98% to $9.7 million in 2025.
• Business Quant data shows GBCS's Revenue at $9.7 million in Q4 2025, $10.8 million in Q3 2025, and $10.4 million in Q2 2025.